POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

D. Van der Heijde; X. Baraliakos; J. Sieper; A. Deodhar; R. Inman; H. Kameda; X. Zeng; Y. Sui; X. Bu; A. Pangan; P. Wung; I. H. Song

doi:10.1136/annrheumdis-2022-eular.2518

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Scientific Abstracts

Poster Tours

AxSpA: About treatments and outcomes

POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

Free

Online download statistics by month:

Online download statistics by month: May 2022 to August 2023

	Abstract	Pdf
May 2022	21	0
Jun 2022	465	56
Jul 2022	352	57
Aug 2022	172	32
Sep 2022	105	10
Oct 2022	72	6
Nov 2022	46	8
Dec 2022	56	13
Jan 2023	64	12
Feb 2023	68	9
Mar 2023	50	8
Apr 2023	80	24
May 2023	81	13
Jun 2023	58	7
Jul 2023	89	16
Aug 2023	31	6
Total	1810	277

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: May 2022 to August 2023

Read the full text or download the PDF:

Log in using your username and password